| Varieties: | General Disease Prevention Medicine |
|---|---|
| Component: | Animal |
| Type: | The First Class |
| Pharmacodynamic Influential Factors: | Animal Species |
| Storage Method: | Light Proof |
| Veterinary Reg. No.: | 3004909099 |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier | [Product Name]: Furosemide Tablets [Main ingredients]: Furosemide [Properties]: White tablet [Pharmacological action]: Furosemide acts mainly on the medullary part of the ascending branch of the renal tubular medullary collaterals, inhibiting their reabsorption of Cl- and Na+, and also on the cortical part of the ascending branch. The result is an increase in luminal fluid Na+ and Cl- concentrations, a decrease in intramedullary fluid Na+ and Cl- concentrations, and a decrease in renal tubular concentration, which leads to an increase in water, Na+, and Cl- excretion. As Na+ reabsorption decreases, distal tubular Na+ concentration increases, promoting increased Na+- K+ and Na+- H+ exchange, resulting in increased K+ and H+ excretion. In addition, furosemide inhibits Na+ and Cl- reabsorption in the proximal and distal convoluted tubules, which enhances Na+- K+ exchange in the distal convoluted tubules and promotes K+ excretion. Pharmacokinetics It is easily absorbed internally, with peak blood concentration in dogs 1~2 hours after internal administration, bioavailability up to 77%, and half-life about 1~1.5 hours. Nearly 50%-60% of the dose is excreted in the urine in its original form, the rest is combined with glucuronide. In renal insufficiency, the plasma half-life is prolonged and the amount should be adjusted at the time of administration. [Function]: Diuretic. Used for various edema disorders. [Usage and Dosage] For internal use: 2.5~5mg per 1kg body weight for dogs and cats. or as directed by a veterinary physician. |
| The Bochongan brand is a new pet medical brand created by the pet business department of Jiangxi Bolai Pharmacy Co., Ltd. in 2020, and it is also the key layout of the Bolai Group in the pet medical field. Bolai Group was established on August 28, 1999. In the past 23 years since its establishment, it has grown from a single enterprise to a large-scale agricultural industry integrating scientific research, production, and chemical group. Now it owns Jiangxi BOLAI Pharmacy Co., Ltd., Jiangxi Bolai Agricultural High-tech Co., Ltd., and other 9 companies. It covers all-around research and development of topics in the fields of improved breeding, ecological breeding, feed processing, veterinary drug production, animal drug research and development, biological product research and development, agricultural industrialization, pig slaughtering and processing, and deep processing of meat products Industry, eco-tourism light, cold chain logistics, animal diagnosis and treatment and other industries. Bolai Pharmacy, a subsidiary of Bolai Group, currently has 23 automated production lines that have passed the GMP certification of the Ministry of Agriculture. It is one of the largest animal drug production bases in China with the most complete product categories. Combined with the medical needs of the diagnosis and treatment end, develop a series of pet medical and health care products to comprehensively care for the health of pets. |
 |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}